TABLE 6.
First-line treatment | 4 cycles Carboplatin+etoposide+atezolizumab | Maintenance atezolizumab |
4 cycles Platinum+etoposide+durvalumab | Maintenance durvalumab | |
4–6 cycles Carboplatin+etoposide | ||
Carboplatin+oral topotecan | ||
Cisplatin+irinotecan | ||
Second-line treatment | Oral or i.v. topotecan |